These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 36371175)

  • 41. Clinical Phenotype, Immunological Abnormalities, and Genomic Findings in Patients with DiGeorge Spectrum Phenotype without 22q11.2 Deletion.
    Cirillo E; Prencipe MR; Giardino G; Romano R; Scalia G; Genesio R; Nitsch L; Pignata C
    J Allergy Clin Immunol Pract; 2020 Oct; 8(9):3112-3120. PubMed ID: 32668295
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Molecular screening for 22Q11.2 deletion syndrome in patients with congenital heart disease.
    Huber J; Peres VC; de Castro AL; dos Santos TJ; da Fontoura Beltrão L; de Baumont AC; Cossio SL; Dalberto TP; Riegel M; Cañedo AD; Schaan BD; Pellanda LC
    Pediatr Cardiol; 2014 Dec; 35(8):1356-62. PubMed ID: 24880467
    [TBL] [Abstract][Full Text] [Related]  

  • 43. An overview of the trajectory of Brazilian individuals with 22q11.2 deletion syndrome until diagnosis.
    Silva IMW; Gil-da-Silva-Lopes VL
    Orphanet J Rare Dis; 2022 Feb; 17(1):67. PubMed ID: 35189940
    [TBL] [Abstract][Full Text] [Related]  

  • 44. 22q11.2 deletion syndrome: DiGeorge, velocardiofacial, and conotruncal anomaly face syndromes.
    Cuneo BF
    Curr Opin Pediatr; 2001 Oct; 13(5):465-72. PubMed ID: 11801894
    [TBL] [Abstract][Full Text] [Related]  

  • 45. High prevalence of fatigue in adults with a 22q11.2 deletion syndrome.
    Vergaelen E; Claes S; Kempke S; Swillen A
    Am J Med Genet A; 2017 Apr; 173(4):858-867. PubMed ID: 28190295
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Hypocalcemia and chromosome 22q11 microdeletion.
    Garabédian M
    Genet Couns; 1999; 10(4):389-94. PubMed ID: 10631928
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Symptomatic hypoparathyroidism based on a 22q11 deletion first diagnosed in a 43-year-old woman.
    van den Berge K; Diderich K; Poddighe P; Berghout A
    Neth J Med; 2009 Mar; 67(3):102-4. PubMed ID: 19307681
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Congenital diaphragmatic hernia in 22q11.2 deletion syndrome.
    Unolt M; DiCairano L; Schlechtweg K; Barry J; Howell L; Kasperski S; Nance M; Adzick NS; Zackai EH; McDonald-McGinn DM
    Am J Med Genet A; 2017 Jan; 173(1):135-142. PubMed ID: 27682988
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Hypocalcemia impacts heart failure control in DiGeorge 2 syndrome.
    Chao PH; Chao MC; Hwang KP; Chung MY
    Acta Paediatr; 2009 Jan; 98(1):195-8. PubMed ID: 18795911
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Head and neck manifestations of 22q11.2 deletion syndromes.
    Marom T; Roth Y; Goldfarb A; Cinamon U
    Eur Arch Otorhinolaryngol; 2012 Feb; 269(2):381-7. PubMed ID: 21861138
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Parkinson's disease with hypocalcaemia: adult presentation of 22q11.2 deletion syndrome.
    Moreira F; Brás A; Lopes JR; Januário C
    BMJ Case Rep; 2018 Mar; 2018():. PubMed ID: 29572372
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Growth characteristics and endocrine abnormalities in 22q11.2 deletion syndrome.
    Levy-Shraga Y; Gothelf D; Goichberg Z; Katz U; Somech R; Pinhas-Hamiel O; Modan-Moses D
    Am J Med Genet A; 2017 May; 173(5):1301-1308. PubMed ID: 28421700
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Challenges in genetic diagnosis, co-occurrence of 22q11.2 deletion syndrome and Noonan syndrome.
    Chinton J; Huckstadt V; Foncuberta ME; Perez MM; Bonetto MC; Gravina LP; Obregon MG
    Am J Med Genet A; 2022 Aug; 188(8):2505-2508. PubMed ID: 35689529
    [TBL] [Abstract][Full Text] [Related]  

  • 54. antiphospholipid antibodies syndrome associated with hyperhomocysteinemia related to MTHFR Gene C677T and A1298C heterozygous mutations in a young man with idiopathic hypoparathyroidism (DiGeorge syndrome).
    Nucera C; Vaccaro M; Moleti M; Priolo C; Tortorella G; Angioni A; Ientile R; Violi MA; Loda M; Trimarchi F; Vermiglio F
    J Clin Endocrinol Metab; 2006 Jun; 91(6):2021-6. PubMed ID: 16595601
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Co-occurrence of 22q11 deletion syndrome and HDR syndrome.
    Fukai R; Ochi N; Murakami A; Nakashima M; Tsurusaki Y; Saitsu H; Matsumoto N; Miyake N
    Am J Med Genet A; 2013 Oct; 161A(10):2576-81. PubMed ID: 23918631
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Delayed-onset hypoparathyroidism in an adolescent with chromosome 22Q11 deletion syndrome.
    Kambo JS; Girgis CM; Champion BL; Wall JR
    Endocr Pract; 2011; 17(5):e123-5. PubMed ID: 21803718
    [TBL] [Abstract][Full Text] [Related]  

  • 57. 22q11.2 deletion syndrome lowers seizure threshold in adult patients without epilepsy.
    Wither RG; Borlot F; MacDonald A; Butcher NJ; Chow EWC; Bassett AS; Andrade DM
    Epilepsia; 2017 Jun; 58(6):1095-1101. PubMed ID: 28448680
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Extracardiac features predicting 22q11.2 deletion syndrome in adult congenital heart disease.
    Fung WL; Chow EW; Webb GD; Gatzoulis MA; Bassett AS
    Int J Cardiol; 2008 Dec; 131(1):51-8. PubMed ID: 18191243
    [TBL] [Abstract][Full Text] [Related]  

  • 59. A patient with 22q11.2 deletion syndrome: case report.
    Eryılmaz SK; Baş F; Satan A; Darendeliler F; Bundak R; Günöz H; Saka N
    J Clin Res Pediatr Endocrinol; 2009; 1(3):151-4. PubMed ID: 21274400
    [TBL] [Abstract][Full Text] [Related]  

  • 60. A rare mosaic 22q11.2 microdeletion identified in a Chinese family with recurrent fetal conotruncal defects.
    Chen W; Li X; Sun L; Sheng W; Huang G
    Mol Genet Genomic Med; 2019 Aug; 7(8):e847. PubMed ID: 31297990
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.